97 related articles for article (PubMed ID: 14751267)
41. A coupled protein and probe engineering approach for selective inhibition and activity-based probe labeling of the caspases.
Xiao J; Broz P; Puri AW; Deu E; Morell M; Monack DM; Bogyo M
J Am Chem Soc; 2013 Jun; 135(24):9130-8. PubMed ID: 23701470
[TBL] [Abstract][Full Text] [Related]
42. The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/CED-3 family protease, CPP32, via a novel two-step mechanism.
Martin SJ; Amarante-Mendes GP; Shi L; Chuang TH; Casiano CA; O'Brien GA; Fitzgerald P; Tan EM; Bokoch GM; Greenberg AH; Green DR
EMBO J; 1996 May; 15(10):2407-16. PubMed ID: 8665848
[TBL] [Abstract][Full Text] [Related]
43. Analytical application of the co-fluorescence effect in detection of europium, terbium, samarium and dysprosium with time-resolved fluorimetry.
Xu YY; Hemmilä IA
Talanta; 1992 Jul; 39(7):759-63. PubMed ID: 18965447
[TBL] [Abstract][Full Text] [Related]
44. Quantitative MS-based enzymology of caspases reveals distinct protein substrate specificities, hierarchies, and cellular roles.
Julien O; Zhuang M; Wiita AP; O'Donoghue AJ; Knudsen GM; Craik CS; Wells JA
Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2001-10. PubMed ID: 27006500
[TBL] [Abstract][Full Text] [Related]
45. Inflammatory caspase substrate specificities.
Exconde PM; Bourne CM; Kulkarni M; Discher BM; Taabazuing CY
mBio; 2024 Jun; ():e0297523. PubMed ID: 38837391
[TBL] [Abstract][Full Text] [Related]
46. 131I-labeled peptides as caspase substrates for apoptosis imaging.
Bauer C; Bauder-Wuest U; Mier W; Haberkorn U; Eisenhut M
J Nucl Med; 2005 Jun; 46(6):1066-74. PubMed ID: 15937321
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of recombinant caspase specificity by competitive substrates.
Benkova B; Lozanov V; Ivanov IP; Mitev V
Anal Biochem; 2009 Nov; 394(1):68-74. PubMed ID: 19595985
[TBL] [Abstract][Full Text] [Related]
48. Proteome-wide identification of family member-specific natural substrate repertoire of caspases.
Ju W; Valencia CA; Pang H; Ke Y; Gao W; Dong B; Liu R
Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14294-9. PubMed ID: 17728405
[TBL] [Abstract][Full Text] [Related]
49. Some commonly used caspase substrates and inhibitors lack the specificity required to monitor individual caspase activity.
Pereira NA; Song Z
Biochem Biophys Res Commun; 2008 Dec; 377(3):873-7. PubMed ID: 18976637
[TBL] [Abstract][Full Text] [Related]
50. Assay development and high-throughput screening of caspases in microfluidic format.
Wu G; Irvine J; Luft C; Pressley D; Hodge CN; Janzen B
Comb Chem High Throughput Screen; 2003 Jun; 6(4):303-12. PubMed ID: 12769673
[TBL] [Abstract][Full Text] [Related]
51. Design, synthesis, and evaluation of aza-peptide epoxides as selective and potent inhibitors of caspases-1, -3, -6, and -8.
James KE; Asgian JL; Li ZZ; Ekici OD; Rubin JR; Mikolajczyk J; Salvesen GS; Powers JC
J Med Chem; 2004 Mar; 47(6):1553-74. PubMed ID: 14998341
[TBL] [Abstract][Full Text] [Related]
52. Peptidyl-Resin Substrates as a Tool in the Analysis of Caspase Activity.
Bąchor R
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807352
[TBL] [Abstract][Full Text] [Related]
53. Detection of caspase activation in situ by fluorochrome-labeled caspase inhibitors.
Amstad PA; Yu G; Johnson GL; Lee BW; Dhawan S; Phelps DJ
Biotechniques; 2001 Sep; 31(3):608-10, 612, 614, passim. PubMed ID: 11570504
[TBL] [Abstract][Full Text] [Related]
54. Using Synthetic Peptide Substrates to Measure Drosophila Caspase Activity.
Denton D; Kumar S
Cold Spring Harb Protoc; 2015 Jul; 2015(7):671-3. PubMed ID: 26134908
[TBL] [Abstract][Full Text] [Related]
55. Fluorometric and colorimetric detection of caspase activity associated with apoptosis.
Gurtu V; Kain SR; Zhang G
Anal Biochem; 1997 Aug; 251(1):98-102. PubMed ID: 9300088
[TBL] [Abstract][Full Text] [Related]
56. Convenient synthesis of maleimido-derivatized lanthanide(III) chelates and their use in mercapto group conjugation.
Hovinen J
Bioconjug Chem; 2007; 18(2):597-600. PubMed ID: 17341106
[TBL] [Abstract][Full Text] [Related]
57. Resonance energy transfer from lanthanide chelates to overlapping and nonoverlapping fluorescent protein acceptors.
Vuojola J; Lamminmäki U; Soukka T
Anal Chem; 2009 Jun; 81(12):5033-8. PubMed ID: 19438245
[TBL] [Abstract][Full Text] [Related]
58. Assaying caspase activity in vitro.
McStay GP; Green DR
Cold Spring Harb Protoc; 2014 Jul; 2014(7):774-7. PubMed ID: 24987140
[TBL] [Abstract][Full Text] [Related]
59. Catalytic properties of the caspases.
Stennicke HR; Salvesen GS
Cell Death Differ; 1999 Nov; 6(11):1054-9. PubMed ID: 10578173
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3.
Kolenko V; Bloom T; Rayman P; Bukowski R; Hsi E; Finke J
J Immunol; 1999 Jul; 163(2):590-8. PubMed ID: 10395645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
